Overview
- Queen Letizia presided at Salamanca’s Centro de Investigación del Cáncer, urging investment in research, prevention, technology, services and talent, and calling for equitable, stable financing.
- AECC advanced its Patient Advocacy program that involves patients in evaluating and following research projects, with more than 30 participants from 10 provinces and new public dialogues such as the Vigo forum.
- The CIC marked its 25th year as a reference center, reporting €160 million in funding, over 2,000 publications, participation in more than 1,000 clinical trials, dozens of licensed patents and the creation of seven spin‑offs.
- AECC said it allocates 18% of its income to research and coordinates a national network of about 2,300 researchers across 146 centers working on hundreds of oncology projects.
- Watchdog data highlighted long waits for funded access to new therapies, estimating an average 616 days in Spain after EU authorization compared with about 128 days in Germany, with many drugs funded only with restrictions.